Classification and genetics of dystonia

Lancet Neurology

Volumn 1, Issue 5, 2002, Pages 316-325

  De Carvalho Aguiar, Patricia M ^a,b   Ozelius, Laurie J ^a,b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; CHAPERONE; DOPAMINE; DYT1 PROTEIN, HUMAN;

BRAIN LEVEL; CHROMOSOME MAP; CLASSIFICATION; DYSTONIA; GENETICS; HUMAN; MUTATION; MYOCLONUS; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; REVIEW; BODY POSTURE; CLINICAL FEATURE; DISEASE CLASSIFICATION; GENE LOCUS; GENETIC ANALYSIS; MOLECULAR DYNAMICS; MUSCLE CONTRACTION; ONSET AGE; PARKINSONISM; PHENOTYPE; PRIMARY TORSION DYSTONIA; PRIORITY JOURNAL; SYNDROME DELINEATION; X CHROMOSOME LINKAGE;

BRAIN CHEMISTRY; CARRIER PROTEINS; CHROMOSOME MAPPING; DNA MUTATIONAL ANALYSIS; DOPAMINE; DYSTONIA; HUMANS; MOLECULAR CHAPERONES; MUTATION; MYOCLONUS;

EID: 0141565339     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(02)00137-0     Document Type: Review

References (139)

1. Fahn S., Marsden C.D., Calne D.B. Classification and investigation of dystonia. Marsden C.D., Fahn S. Movement disorders. 2:1987;332-358 Butterworth, London.
2. Fahn S. Concept and classification of dystonia. Adv Neurol. 50:1988;1-8.
3. Fahn S., Bressman S.B., Marsden C.D. Classification of dystonia. Fahn S., Marsden C.D., DeLong M.R. Advances in neurology. 78:1998;1-10 Lippincott-Raven, Philadelphia.
4. Berardelli A., Rothwell J.C., Hallet M., Thompson P.D., Manfredi M., Marsden C.D. The pathophysiology of primary dystonia. Brain. 121:1998;1195-1212.
5. Bressman S.B., de Leon D., Brin M.F., et al. Idiopathic torsion dystonia among Ashkenazi Jews: evidence for autosomal dominant inheritance. Ann Neurol. 26:1989;612-620.
6. Bressman S.B., Sabatti C., Raymond D., et al. The DYT1 phenotype and guidelines for diagnostic testing. Neurology. 54:2000;1746-1752.
7. Greene P., Kang U.J., Fahn S. Spread of symptoms in idiopathic torsion dystonia. Mov Disord. 10:1995;143-152.
8. Nutt J.G., Muenter M.D., Aronson A., Kurland L.T., Melton L.J. III. Epidemiology of focal and generalized dystonia in Rochester, Minnesota. Mov Disord. 3:1988;188-194.
9. A prevalence study of primary dystonia in eight European countries. J Neurol. 247:2000;787-792.
10. Risch N., deLeon D., Ozelius L., et al. Genetic analysis of idiopathic torsion dystonia in Ashkenazi Jews and their recent descent from a small founder population. Nat Genet. 9:1995;152-159.
11. Risch N., Bressman S.B., de Leon D., et al. Segregation analysis of idiopathic torsion dystonia in Ashkenazi Jews suggests autosomal dominant inheritance. Am J Hum Genet. 46:1990;533-538.
12. Zeman W., Dyken P. Dystonia musculorum deformans; clinical, genetic and pathoanatomical studies. Psychiatr Neurol Neurochir. 70:1967;77-121.
13. Defazio G., Livrea P., Guanti G., Lepore V., Ferrari E. Genetic contribution to idiopathic adult-onset blepharospasm and cranial-cervical dystonia. Eur Neurol. 33:1993;345-350.
14. Bressman S.B., Hunt A.L., Heiman G., et al. Inheritance of late-onset idiopathic torsion dystonia. Neurology. 45:(suppl 4):1995;A457[abstr].
15. Waddy H.M., Fletcher N.A., Harding A.E., Marsden C.D. A genetic study of idiopathic focal dystonias. Ann Neurol. 29:1991;320-324.
16. Stojanovic M., Cvetkovic D., Kostic V.S. A genetic study of idiopathic focal dystonias. J Neurol. 242:1995;508-511.
17. Leube B., Kessler K.R., Goecke T., Auburger G., Benecke R. Frequency of familial inheritance among 488 index patients with idiopathic focal dystonia and clinical variability in a large family. Mov Disord. 12:1997;1000-1006.
18. Fletcher N.A., Harding A.E., Marsden C.D. A genetic study of idiopathic torsion dystonia in the United Kingdom. Brain. 113:1990;379-396.
19. Bathia K.P. Familial (idiopathic) paroxysmal dyskinesias: an update. Semin Neurol. 21:2001;69-74.
20. Bressman S.B., de Leon D., Kramer P.L., et al. Dystonia in Ashkenazi Jews: clinical characterization of a founder mutation. Ann Neurol. 36:1994;771-777.
21. Ozelius L., Kramer P., Moskowitz C.B., et al. Human gene for torsion dystonia located on chromosome 9q32-34. Neuron. 2:1989;1427-1434.
22. Warner T., Fletcher N.A., Davis M.B., et al. Linkage analysis in British families with idiopathic torsion dystonia. Brain. 116:1993;739-744.
23. Kramer P.L., Heiman G.A., Gasser T., et al. The DYT1gene on 9q34 is reponsible for most cases of early limb-onset idiopathic torsion dystonia in non-Jews. Am J Hum Genet. 55:1994;468-475.
24. Kramer L.P., de Leon D., Ozelius L., et al. Dystonia gene in Ashkenazi Jewish population located on chromosome 9q32-34. Ann Neurol. 27:1990;114-120.
25. Ozelius L.J., Kramer P.L., de Leon D., et al. Strong allelic association between the torsion dystonia gene (DYT1) and loci on chromosome 9q34 in Ashkenazi Jews. Am J Hum Genet. 50:1992;619-628.
26. Klein C., Brin M.F., de Leon D., et al. De novo mutations (GAG deletion) in the DYT1 gene in two non-Jewish patients with early-onset dystonia. Hum Mol Genet. 7:1998;1133-1136.
27. Ikeuchi T., Shimohata T., Nakano R., Koide R., Takano H., Tsuji S. A case of primary torsion dystonia in Japan with the 3-bp (GAG) deletion in the DYT1 gene with a unique clinical presentation. Neurogenetics. 2:1999;189-190.
28. Valente E.M., Warner T.T., Jarman P.R., et al. The role of DYT1 in primary torsion dystonia in Europe. Brain. 121:1998;2335-2339.
29. Slominski P.A., Markova E.D., Shadrina M.I., et al. A common 3-bp deletion in the DYT1 gene in Russian families with early-onset torsion dystonia. Hum Mutat. 14:1999;269.
30. Lebre A.S., Durr A., Jedtnak P., et al. DYT1 Mutation in French families with idiopathic torsion dystonia. Brain. 122:1999;41-45.
31. Major T., Svetel M., Romac S., Kostic V.S. DYT1 mutation in primary torsion dystonia in a Serbian population. J Neurol. 248:2001;940-943.
32. Klein C., Friedman J., Bressman S., et al. Genetic testing for early-onset torsion dystonia (DYT1): introduction of a simple screening method, experiences from testing of a large patient cohort, and ethical aspects. Genet Test. 3:1999;323-328.
33. Leung J.C., Klein C., Friedman J., et al. Novel mutation in the Tor1A (DYT1) gene in atypical early onset dystonia and polymorphisms in dystonia and early onset parkinsonism. Neurogenetics. 3:2001;133-143.
34. Ozelius L.J., Page C.E., Klein C., et al. The TOR1A (DYT1) gene family and role in early onset torsion dystonia. Genomics. 62:1999;377-384.
35. Dron M., Meritet J.F., Dandoy-Dron F., Meyniel J.P., Maury C., Tovey M.G. Molecular cloning of ADIR, a novel interferon responsive gene encoding a protein related to the torsins. Genomics. 79:2002;315-325.
36. Ozelius L.J., Hewett J., Page C.E., et al. The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein. Nat Genet. 17:1997;40-48.
37. Neuwald A.F., Aravind L., Spouge J.L., Koonin E.V. AAA+: a class of chaperone-like ATPases associated with the assembly, operation, and disassembly of protein complexes. Genome Res. 9:1999;27-43.
38. Vale R.D. AAA proteins: lords of the ring. J Cell Biol. 150:2000;F13-F20.
39. Breakefield X.O., Kamm C., Hanson P.I. TorsinA: movement at many levels. Neuron. 31:2001;9-12.
40. Hewett J., Gonzalez-Agosti C., Slater D., et al. Mutant torsinA, responsible for early-onset torsion dystonia, forms membrane inclusions in cultured neural cells. Hum Mol Genet. 9:2000;1403-1413.
41. Kustedjo K., Bracey M.H., Cravatt B.F. Torsin A and its torsion dystonia-associated mutant forms are lumenal glycoproteins that exhibit distinct subcellular localizations. J Biol Chem. 275:2000;27933-27939.
42. Walker R.H., Brin M.F., Sandu D., Good P.F., Shashidharan P. TorsinA immunoreactivity in brains of patients with DYT1 and non-DYT1 dystonia. Neurology. 58:2002;120-124.
43. Hedreen J.C., Zweig R.M., DeLong M.R., Whitehouse P.J., Price D.L. Primary dystonias: a review of the pathology and suggestions for new directions of study. Adv Neurol. 50:1988;123-132.
44. Augood S.J., Penney J.B. Jr, Friberg I.K., et al. Expression of the early-onset torsion dystonia gene (DYT1) in human brain. Ann Neurol. 43:1998;669-673.
45. Augood S.J., Martin D.M., Ozelius L.J., Breakefield X.O., Penney J.B., Standaert D.G. Distribution of the mRNAs encoding torsinA and torsinB in the normal adult brain. Ann Neurol. 46:1999;761-769.
46. Shashidharan P., Kramer B.C., Walker R.H., Olanow C.W., Brin M.F. Immunohistochemical localization and distribution of torsinA in normal human and rat brain. Brain Res. 853:2000;197-206.
47. Konakova M., Huynh D.P., Yong W., Pulst S.M. Cellular distribution of torsinA and torsinB in normal human brain. Arch Neurol. 58:2001;921-927.
48. Shashidharan P., Good P.F., Hsu A., Perl D., Brin M.F., Olanow C.W. TorsinA accumulation in Lewy bodies in sporadic Parkinson's disease. Brain Res. 877:2000;379-381.
49. Sharma N., McLean P.J., Kawamata H., Irizarry M.C., Hyman B.T. Alpha-synuclein has an altered conformation and shows a tight intermolecular interaction with ubiquitin in Lewy bodies. Acta Neuropathol (Berl). 102:2001;329-334.
50. Furukawa Y., Hornykiewicz O., Fahn S., Kish S.J. Striatal dopamine in early-onset primary torsion dystonia with the DYT1 mutation. Neurology. 54:2000;1193-1195.
51. Eldridge R.A. The torsion dystonias: literature review, genetic and clinical studies. Neurology. 20:(suppl 2):1970;1-78.
52. Zilber N., Korczyn A.D., Kahana E., Fried K., Alter M. Inheritance of idiopathic torsion dystonia among Jews. J Med Genet. 21:1984;13-26.
53. Pauls D.L., Korczyn A.D. Complex segregation analysis of dystonia pedigrees suggests autosomal dominant inheritance. Neurology. 40:1990;1107-1110.
54. Gimenez-Roldan S., Delgado G., Marin M., Villanueva J.A., Mateo D. Hereditary torsion dystonia in gypsies. Adv Neurol. 50:1988;73-81.
55. Parker N. Hereditary whispering dysphonia. J Neurol Neurosurg Psychiatry. 48:1985;218-224.
56. Ahmad F., Davis M.B., Waddy H.M., Oley C.A., Marsden C.D., Harding A.E. Evidence for locus heterogeneity in autosomal dominant torsion dystonia. Genomics. 15:1993;9-12.
57. Holmgren G., Ozelius L., Forsgren L., et al. Adult onset idiopathic torsion dystonia is excluded from the DYT1 region (9q34) in a Swedish family. J Neurol Neurosurg Psychiatry. 59:1995;178-181.
58. Bressman S.B., Warner T.T., Almasy L., et al. Exclusion of the DYT1 Locus in familial torticollis. Ann Neurol. 40:1996;681-684.
59. Bentivoglio A.R., Del Grosso N., Albanese A., Cassetta E., Tonali P., Frontali M. Non-DYT1 dystonia in a large Italian family. J Neurol Neurosurg Psychiatry. 62:1997;357-360.
60. Lossos A., Cohen O., Meiner V., Blumenfeld A., Reches A. Intrafamilial heterogeneity of movement disorders: report of three cases in one family. J Neurol. 244:1997;426-430.
61. Valente E.M., Bentivoglio A.R., Cassetta E., et al. DYT13, a novel primary torsion dystonia locus, maps to chromosome 1p36.13-36.32 in an Italian family with cranial-cervical or upper limb onset. Ann Neurol. 49:2001;362-364.
62. Bressman S.B., Hunt A.L., Heiman G.A., et al. Exclusion of the DYT1 locus in a non-Jewish family with early-onset dystonia. Mov Disord. 9:1994;626-632.
63. Almasy L., Bressman S.B., Raymond D., et al. Idiopathic torsion dystonia linked to chromosome 8 in two Mennonite families. Ann Neurol. 42:1997;670-673.
64. Leube B., Doda R., Ratzlaff T., Kessler K., Benecke R., Auburger G. Idiopathic torsion dystonia: assignment of a gene to chromosome 18p in a German family with adult onset, autosomal inheritance and purely focal distribution. Hum Mol Genet. 5:1996;1673-1677.
65. Leube B., Hendgen T., Kessler K.R., Knapp M., Benecke R., Auburger G. Sporadic focal dystonia in Northwest Germany:molecular basis on chromosome 18p. Ann Neurol. 42:1997;111-114.
66. Leube B., Hendgen T., Kessler K.R., Knapp M., Benecke R., Auburger G. Evidence for DYT7 being a common cause of cervical dystonia (torticollis) in Central Europe. Am J Med Genet. 74:1997;529-532.
67. Klein C., Ozelius L., Hagenah J., Breakefield X.O., Risch N.J., Vieregge P. Search for a founder mutation in idiopathic focal dystonia from Northern Germany. Am J Hum Genet. 63:1998;1777-1782.
68. Leube B., Auburger G. Questionable role of adult-onset focal dystonia among sporadic dystonia patients. Ann Neurol. 44:1998;984-985.
69. Klein C., Page C.E., LeWitt P., et al. Genetic analysis of three patients with an 18p- syndrome and dystonia. Neurology. 52:1999;649-651.
70. Tezzon F., Zanoni T., Passarin M.G., Ferrari G. Dystonia in a patient with deletion of 18p. Ital J Neurol Sci. 19:1998;90-93.
71. Bonifati V., Breedveld G.J., Squitieri F., et al. Localization of autosomal recessive early-onset parkinsonism to chromosome 1p36 (PARK7) in an independent data set. Ann Neurol. 51:2002;253-256.
72. Jarman P., Valente E.M., Leube B., et al. Primary torsion dystonia: the search for genes is not over. J Neurol Neurosurg Psychiatry. 67:1999;395-397.
73. Klein C., Pramstaller P.P., Castellan C.C., Breakefield X.O., Kramer P.L., Ozelius L.J. Clinical and genetic evaluation of a family with a mixed dystonia phenotype from South Tyrol. Ann Neurol. 44:1998;394-398.
74. Münchau A., Valente E.M., Davis M.B., et al. A Yorkshire family with adult-onset cranio-cervical primary torsion dystonia. Mov Disord. 15:2000;954-959.
75. Placzec M.R., Misbahuddin A., Chaudhuri K.R., Wood N.W., Bathia K.P., Warner T.T. Cervical dystonia is associated with a polymorphism in the dopamine (D5) receptor gene. J Neurol Neurosurg Psychiatry. 71:2001;262-264.
76. Misbahuddin A., Placzec M.R., Chaudhuri K.R., Wood N.W., Bathia K.P., Warner T.T. A polymorphism in the dopamine receptor DRD5 is associated with blepharospasm. Neurology. 58:2002;124-126.
77. Segawa M., Hosaka A., Miyagawa F., Nomura Y., Imai H. Hereditary progressive dystonia with marked diurnal fluctuation. Adv Neurol. 14:1976;215-233.
78. Nygaard T.G., Marsden C.D., Fahn S. Dopa-responsive dystonia: long-term treatment response and prognosis. Neurology. 41:1991;174-181.
79. Saunders-Pullman R., Eidelberg D., Nygaard T., Raymond D., Bressman S. Typical parkinsonism in dopa-responsive dystonia. Ann Neurol. 42:1997;447. (abstr).
80. Di Capua M., Bertini E. Remission in dihydroxyphenylalanine-responsive dystonia. Mov Disord. 10:1995;223.
81. Steinberger D., Topka H., Fischer D., Müller U. GCH1 mutation in a patient with adult-onset oromandibular dystonia. Neurology. 52:1999;877-879.
82. Nygaard T.G., Waran S.P., Levine R.A., Naini A.B., Chutorian A.M. Dopa-responsive dystonia simulating cerebral palsy. Pediatr Neurol. 11:1994;236-240.
83. Kong C.K., Ko C.H., Tong S.F., Lam C.W. Atypical presentation of dopa-responsive dystonia: generalized hypotonia and proximal weakness. Neurology. 57:2001;1121-1124.
84. Bonifati V., De Michele G., Lüking C.B., et al. The parkin gene and its phenotype. Neurol Sci. 22:2001;5152.
85. Tassin J., Dürr A., Bonnet A.-M., et al. Levodopa-responsive dystonia: GTP cyclohydrolase I or parkin mutations? Brain. 123:2000;1112-1121.
86. Nygaard T.G., Wilhelmsen K.C., Risch N.J., et al. Linkage mapping of dopa-responsive dystonia (DRD) to chromosome 14q. Nat Genet. 5:1993;386-391.
87. Ichinose H., Ohye T., Takahiashi E., et al. Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene. Nat Genet. 8:1994;236-242.
88. Furukawa Y., Land A.E., Trugman J.M., et al. Gender-related penetrance and de novo GTP-cyclohydrolase I gene mutations in dopa-responsive dystonia. Neurology. 50:1998;1015-1020.
89. Ichinose H., Suzuki T., Inagaki H., Ohye T., Nagatsu T. Molecular genetics of dopa-resposive dystonia. Biol Chem. 380:1999;1355-1364.
90. Takahashi H., Levine R.A., Galloway M.P., Snow B.J., Calne D.B., Nygaard T.G. Biochemical and fluorodopa position emmision tomographic finding in an asymptomatic carrier of the gene for dopa-responsive dystonia. Ann Neurol. 35:1994;354-356.
91. Hirano M., Yanagihara T., Ueno S. Dominant- negative effect of GTP cyclohydrolase I mutations in dopa- responsive hereditary progressive dystonia. Ann Neurol. 44:1998;365-371.
92. Bandmann O., Valente E.M., Holmans P., et al. Dopa-responsive dystonia: a clinical and molecular genetic study. Ann Neurol. 44:1998;649-656.
93. Steinberger D., Korinthenberg R., Topka H., Berghäuser M., Wedde R., Müller U. Dopa-responsive dystonia: Mutation analysis of GCH1 and analysis of therapeutic doses of L-dopa. Neurology. 55:2000;1735-1737.
94. Furukawa Y., Guttman M., Sparagana S.P., et al. Dopa-responsive dystonia due to a large deletion in the GTP cyclohydrolase I gene. Ann Neurol. 47:2000;517-520.
95. Lüdecke B., Dworniczak B., Bartholomé K. A point mutation in tyrosine hydroxylase gene associated with Segawa's syndrome. Hum Genet. 95:1995;123-125.
96. Knappskog P.M., Flatmark T., Mallet J., Lüdecke B., Bartholomé K. Recessively inherited L-DOPA- responsive dystonia caused by a point mutation (Q381K) in the tyrosine hydroxylase gene. Hum Mol Genet. 4:1995;1209-1212.
97. Bräutigam C., Wevers R.A., Jansen R.J.T., et al. Biochemical hallmarks of tyrosine hydroxylase deficiency. Clin Chem. 44:1998;1897-1904.
98. Furukawa Y., Graf W.D., Wong H., Shimadzu M., Kish S.J. Dopa-responsive dystonia simulating spastic paraplegia due to tyrosine hydroxylase (TH) gene mutations. Neurology. 56:2001;260-263.
99. Thöny B., Blau N. Mutations in the GTP cyclohydrolase I and 6-pyruvoyl-tetrahydropterin synthase genes. Hum Mutat. 10:1997;11-20.
100. Hirano M., Ueno S. Mutant GTP cyclohydrolase I in autosomal dominant and recessive hyperphenylalaninemia. Neurology. 52:1999;182-184.
101. Bonafe L., Thony B., Penzien J.M., Czarnecki B., Blau N. Mutations in the sepiapterin reductase gene cause a novel tetrahydrobiopterin-dependent monoamine-neurotransmitter deficiency without hyperphenylalaninemia. Am J Hum Genet. 69:2001;269-277.
102. Blau N., Bonafe L., Thöny B. Tetrahydrobiopterin deficiencies without hyperphenylalaninemia: diagnosis and genetics of dopa-responsive dystonia and sepiapterin reductase deficiency. Mol Genet Metab. 74:2001;172-185.
103. Hyland K., Surtees R.H.A., Rodeck C., Clayton P.T. Aromatic L-amino- acid decarboxylase deficiency: clinical features, diagnosis, and treatment of a new inborn error of neurotransmitter amine synthesis. Neurology. 42:1992;1980-1988.
104. Quinn N.P. Essential myoclonus and myoclonic dystonia. Mov Disord. 11:1996;119-124.
105. Quinn N.P., Rothwell J.C., Thompson P.D., Marsden C.D. Hereditary myoclonic dystonia, hereditary torsion dystonia and hereditary essential myoclonus: an area of confusion. Adv Neurol. 50:1988;391-401.
106. Quinn N.P., Marsden C.D. Dominantly inherited myoclonic dystonia with dramatic response to alcohol. Neurology. 34:(suppl 1):1984;236.
107. Mahloudji M., Pikielny R.T. Hereditary essential myoclonus. Brain. 90:1967;669-674.
108. Kyllerman M., Forsgren L., Sanner G., Holmgren G., Wahlstrom J., Drugge U. Alcohol responsive myoclonic dystonia in a large family: dominant inheritance and phenotypic variation. Mov Disord. 5:1990;270-279.
109. Nygaard T.G., Raymond D., Chen C., et al. Localization of a gene for myoclonus dystonia to chromosome 7q21-31. Ann Neurol. 46:1999;794-798.
110. Saunders-Pullman R., Shriberg J., Heiman G., et al. Myoclonus dystonia: possible association with obsessive-compulsive disorder and alcohol dependence. Neurology. 58:2002;242-245.
111. Klein C., Schilling K., Saunders-Pullman R.J., et al. A major locus for myoclonus-dystonia maps to chromosome 7q in eight families. Am J Hum Genet. 67:2000;1314-1319.
112. Vidailhet M., Tassin J., Durif F., et al. A major locus for several phenotypes of myoclonus-dystonia on chromosome 7q. Neurology. 56:2001;1213-1216.
113. Asmus F., Zimprich A., Naumann M., et al. Inherited Myoclonus-dystonia syndrome: narrowing the 7q21-q31 locus in German families. Ann Neurol. 49:2001;121-124.
114. Zimprich A., Grabowski M., Asmus F., et al. Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-dystonia syndrome. Nat Genet. 29:2001;66-69.
115. Ozelius L, Liu L, Kock N, et al. Mutation analysis of the epsilon-sarcoglycan (SGCE) gene in ten families with myoclonus-dystonia [abstr P05.143]. Neurology (in press).
116. Asmus F, Zimprich A, Tezenas S et al. Spectrum of mutations in the gene for epsilon-sarcoglycan (SGCE) in myoclonus-dystonia syndrome (MDS, DYT11) [abstr S07.005]. Neurology (in press).
117. Piras G., El Kharroubi A., Kozlov S., et al. Zac1 (Lot1), a potential tumor suppressor gene, and the gene for epsilon-sarcoglycan are maternally imprinted genes: identification by a subtractive screen of novel uniparental fibroblast lines. Mol Cell Biol. 20:2000;3308-3315.
118. Lim L.E., Campbell K.P. The sarcoglycan complex in limb-girdle muscular dystrophy. Curr Opin Neurol. 11:1998;443-452.
119. Hack A., Groh M.E., McNally E.M. Sarcoglycans in muscular dystrophy. Microsc Res Tech. 48:2000;167-180.
120. Ettinger A.J., Feng G., Sanest J.R. epsilon-Sarcoglican, a broadly expressed homologue of the gene mutated in limb-girdle muscular dystrophy 2D. J Biol Chem. 272:1997;32534-32538.
121. Klein C., Brin M.F., Kramer P., et al. Association of a missense change in the D2 dopamine receptor with myoclonus dystonia. Proc Natl Acad Sci USA. 96:1999;5173-5176.
122. Klein C., Gurvich N., Sena-Esteves M., et al. Evaluation of the role of the D2 dopamine receptor in myoclonus-dystonia. Ann Neurol. 47:2000;369-373.
123. Durr A., Tassin J., Vidailhet M., et al. D2 dopamine receptor gene in myoclonic dystonia and essential myoclonus. Ann Neurol. 48:2000;127-128.
124. Grimes D.A., Bulman D., George-Hyslop P.S., Lang A.E. Inherited myoclonus-dystonia: evidence supporting genetic heterogeneity. Mov Disord. 16:2001;106-110.
125. Grimes DA, Han F, Lang AE, Bulman DE, A novel locus and sequencing of candidate genes for inherited myoclonus-dystonia on chromosome 18p11 [Abstract S07.004]. Neurology in press.
126. Dobyns W.B., Ozelius L.J., Kramer P.L., et al. Rapid-onset dystonia-parkinsonism. Neurology. 43:1993;2596-2602.
127. Brashear A., de Leon D., Bressman S.B., Thyagarajan D., Farlow M.R., Dobyns W.B. Rapid-onset dystonia-parkinsonism in a second family. Neurology. 48:1997;1066-1069.
128. Webb D.W., Broderick A., Brashear A., Dobyns W.B. Rapid onset dystonia-parkinsonism in a 14-year-old girl. Europ J Paediatr Neurol. 3:1999;171-173.
129. Pittock S.J., Joyce C., O'Keane V., et al. Rapid-onset dystonia-parkinsonism: a clinical and genetic analysis of a new kindred. Neurology. 55:2000;991-995.
130. Brashear A., Butler I.J., Hyland K., Farlow M.R., Dobyns W.B. Cerebrospinal fluid homovanillic acid levels in rapid-onset dystonia-parkinsonism. Ann Neurol. 43:1998;521-526.
131. Brashear A., Mulholland G.K., Zheng Q.-H., Farlow M.R., Siemers E.R., Hutchins G.D. PET imaging of the pre-synaptic dopamine uptake sites in rapid-onset dystonia-parkinsonism (RDP). Mov Disord. 14:1999;132-137.
132. Kramer P.L., Mineta M., Klein C., et al. Rapid-onset dystonia-parkinsonism: linkage to chromosome 19q13. Ann Neurol. 46:1999;176-182.
133. Lee L.V., Pascasio F.M., Fuentes F.D., Viterbo G.H. Torsion dystonia in Panay, Philippines. Adv Neurol. 14:1976;137-151.
134. Kupke K.G., Lee L., Mueller U. Assignment of the X-linked torsion dystonia gene to Xq21 by linkage analysis. Neurology. 40:1990;1438-1442.
135. Wilhelmsen K.C., Weeks D.E., Nygaard T.G., et al. Genetic mapping of 'Lubag' (X-linked dystonia-parkinsonism) in a Filipino kindred to the pericentromeric region of the X chromosome. Ann Neurol. 29:1991;124-131.
136. Waters C.H., Takahashi H., Wilhelmsen K.C., et al. Phenotypic expression of X-linked dystonia-parkinsonism (lubag) in two women. Neurology. 43:1993;1555-1558.
137. Waters C.H., Faust P.L., Powers J., et al. Neuropathology of lubag (X-linked dystonia parkinsonism). Mov Disord. 8:1993;387-390.
138. Graeber M.B., Kupke K.G., Muller U. Delineation of dystonia-parkinsonism syndrome locus syndrome locus in Xq13. Proc Natl Acad Sci USA. 89:1992;8245-8248.
139. Nemeth A.H., Nolte D., Dunne E., et al. Refined linkage disequilibrium and physical mapping of the gene locus for X-linked dystonia-parkinsonism (DYT3). Genomics. 60:1999;320-329.